1. Home
  2. PDSB vs JSPR Comparison

PDSB vs JSPR Comparison

Compare PDSB & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.96

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$1.56

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDSB
JSPR
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.5M
43.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDSB
JSPR
Price
$0.96
$1.56
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$9.00
$18.13
AVG Volume (30 Days)
686.2K
1.1M
Earning Date
11-13-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$1.39
52 Week High
$2.20
$7.19

Technical Indicators

Market Signals
Indicator
PDSB
JSPR
Relative Strength Index (RSI) 54.58 41.71
Support Level $0.92 $1.48
Resistance Level $1.02 $1.68
Average True Range (ATR) 0.09 0.15
MACD 0.01 -0.03
Stochastic Oscillator 51.06 21.21

Price Performance

Historical Comparison
PDSB
JSPR

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: